S&S Healthcare Holding Valuation

Is 4198 undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

2/6

Valuation Score 2/6

Below Fair Value
Significantly Below Fair Value
Price-To-Earnings vs Peers
Price-To-Earnings vs Industry
Price-To-Earnings vs Fair Ratio
Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of 4198 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: Insufficient data to calculate 4198's fair value for valuation analysis.

Significantly Below Fair Value: Insufficient data to calculate 4198's fair value for valuation analysis.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for 4198?

Key metric: As 4198 is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.

The above table shows the Price to Earnings ratio for 4198. This is calculated by dividing 4198's market cap by their current earnings.
What is 4198's PE Ratio?
PE Ratio	7.3x
Earnings	NT$105.74m
Market Cap	NT$775.07m

4198 key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Key Statistics
Enterprise Value/Revenue	2.5x
Enterprise Value/EBITDA	-13.6x
PEG Ratio	n/a

Price to Earnings Ratio vs Peers

How does 4198's PE Ratio compare to its peers?

The above table shows the PE ratio for 4198 vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
Company	Forward PE	Estimated Growth	Market Cap
Peer Average	63x
4744 CVC Technologies	99.8x	n/a	NT$1.1b
6730 Lagis Enterprise	16.7x	n/a	NT$1.2b
6493 Ttbio	117x	n/a	NT$502.6m
4116 BenQ Medical Technology	18.4x	n/a	NT$2.1b
4198 S&S Healthcare Holding	7.3x	n/a	NT$775.1m

Price-To-Earnings vs Peers: 4198 is good value based on its Price-To-Earnings Ratio (7.3x) compared to the peer average (63x).

Price to Earnings Ratio vs Industry

How does 4198's PE Ratio compare vs other companies in the TW Medical Equipment Industry?

0 Companies	Price / Earnings	Estimated Growth	Market Cap

No more companies available in this PE range

0 Companies		Estimated Growth	Market Cap

No more companies

Price-To-Earnings vs Industry: 4198 is good value based on its Price-To-Earnings Ratio (7.3x) compared to the TW Medical Equipment industry average (19.6x).

Price to Earnings Ratio vs Fair Ratio

What is 4198's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

4198 PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio	7.3x
Fair PE Ratio	n/a

Price-To-Earnings vs Fair Ratio: Insufficient data to calculate 4198's Price-To-Earnings Fair Ratio for valuation analysis.

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

Analyst Forecast: Insufficient data to show price forecast.

Discover undervalued companies

Universal Vision Biotechnology

NT$18.3b

Operates a chain of eye care clinics in Taiwan and China.

3218

NT$215.50

1.9%

-27.1%

Hi-Clearance

NT$6.2b

Supplies medical devices for the renal, cardiac, radiation, dental, oral surgery, and metabolism markets in Taiwan.

1788

NT$138.50

0.4%

2.6%

Pacific Hospital Supply

NT$6.5b

Manufactures, processes, and sells medical disposable products and equipment in Taiwan.

4126

NT$89.00

-0.3%

6.0%